Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide.

Flis, Sylwia

Inhibitory effects of 5-fluorouracil and oxaliplatin on human colorectal cancer cell survival are synergistically enhanced by sulindac sulfide. [electronic resource] - Anticancer research Jan 2009 - 435-41 p. digital

Publication Type: Journal Article

0250-7005


Animals
Antineoplastic Combined Chemotherapy Protocols--pharmacology
Apoptosis--drug effects
BALB 3T3 Cells
Cell Cycle--drug effects
Cell Growth Processes--drug effects
Cell Survival--drug effects
Colorectal Neoplasms--drug therapy
Drug Synergism
Fluorouracil--administration & dosage
HT29 Cells
Humans
Mice
Organoplatinum Compounds--administration & dosage
Oxaliplatin
Sulindac--administration & dosage